Inthetech Co., Ltd is going to start globalizing cognitive rehabilitation system, EYAS. The enterprise's goal is to release new EYAS products in the first half of this year and to focus on exports through the establishment of a local subsidiary overseas, which achieve 6 billion won in sales this year.
In the first half of the year, the company will release EYAS tablet version and diagnostic kits. The kit is a Korean dementia diagnostic kit that consider domestic conditions and user's characteristics by applying the Korean dementia screening test (MMSE-K).
This year, this enterprise will speed up to extend in overseas markets
. Cleveland Clinic Lou Rubo Brain Health Center
which is located in Las Vegas is conducting EYAS clinical trial
. The company will set up a corporation in the U.K.
this year and participate in a health and social welfare exhibition in London in June. In order to extend into overseas markets, EYAS Premium Products will push for second-class certification of medical devices this year and plan to receive certification of Conformite Europeen Marking (CE) and the U.S. Food and Drug Administration (FDA) in the future.